Jeffrey Luber, Clairity - AI-Driven Breast Cancer Risk Prediction | LSI USA '25

Clairity specializes in artificial intelligence-driven solutions, revolutionizing healthcare diagnostics by providing real-time, data-driven insights to enhance patient outcomes and streamline clinical workflows.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Jeffrey Luber
Jeffrey Luber
CEO, Clairity